United States · FDA National Drug Code directory
SENNA-S
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69517-131_083396b6-6a49-ffc7-e063-6294a90ad8e2
- Product NDC
- 69517-131
- Form
- TABLET, COATED
- Composition / generic term
- Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg
- Labeler
- HealthLife of USA LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20160307
- Source listing expiry
- 20261231
Source-listed ingredients
- SENNOSIDES — 8.6 mg/1
- DOCUSATE SODIUM — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 POUCH in 1 POUCH (69517-131-02) / 2 TABLET, COATED in 1 POUCH · 69517-131-02
- 1000 BOTTLE in 1 BOTTLE (69517-131-10) / 500 BOTTLE in 1 BOTTLE (69517-131-05) / 24 CARTON in 1 BOTTLE (69517-131-24) / 1 TABLET, COATED in 1 CARTON · 69517-131-10
- 25 POUCH in 1 BOX (69517-131-25) / 2 TABLET, COATED in 1 POUCH · 69517-131-25
- 50 POUCH in 1 BOX (69517-131-50) / 2 TABLET, COATED in 1 POUCH · 69517-131-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →